Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity - Concepedia

Concepedia

Publication | Closed Access

Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity

52

Citations

23

References

2012

Year

Avichai Shimoni, Noga Shem‐Tov, Yulia Volchek, Ivetta Danylesko, Ronit Yerushalmi, A Nagler

Bone Marrow Transplantation

Pharmaceutical ScienceMedicineBu-based RegimensToxicity VsToxicologyPharmacotherapyPharmacologyPharmaceutical Chemistry

References

	Year	Citations

Page 1